|
US274651A
(en)
|
|
1883-03-27 |
|
Advertising-windmill |
|
US4623620A
(en)
|
1983-08-02 |
1986-11-18 |
Stichting Vrienden Van De Stichting Dr. Karl Landsteiner |
Enucleated granulocytes, their preparation and use
|
|
IL78703A
(en)
|
1985-05-10 |
1993-02-21 |
Benzon Alfred |
Method of producing extracellular enzymes, the enzymes produced thereby and compositions containing them; a hybrid plasmid and a dna fragment comprising dna encoding the enzymes; a microorganism harbouring the plasmid; and a method for removing nucleic acids from biological materials
|
|
CA2096222C
(en)
|
1990-11-13 |
1998-12-29 |
Stephen D. Lupton |
Bifunctional selectable fusion genes
|
|
ATE245703T1
(de)
|
1992-09-22 |
2003-08-15 |
Biofocus Discovery Ltd |
Rekombinante viren, die an ihrer äusseren oberfläche ein nichtvirales polypeptid präsentieren
|
|
US6534051B1
(en)
|
1992-11-20 |
2003-03-18 |
University Of Medicine And Dentistry Of New Jersey |
Cell type specific gene transfer using retroviral vectors containing antibody-envelope fusion proteins and wild-type envelope fusion proteins
|
|
WO1994028143A1
(en)
|
1993-05-21 |
1994-12-08 |
Targeted Genetics Corporation |
Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene
|
|
JPH10501403A
(ja)
|
1994-03-04 |
1998-02-10 |
ユニバーシティ オブ メディシン アンド デンティストリー オブ ニュージャージー |
抗体−エンベロープ融合タンパク質および野生型エンベロープ融合タンパク質を含むレトロウィルスベクターを用いる細胞型特異的遺伝子移入
|
|
AU2589095A
(en)
|
1994-05-16 |
1995-12-05 |
Washington University |
Cell membrane fusion composition and method
|
|
WO1997004748A2
(en)
|
1995-08-01 |
1997-02-13 |
Advanced Therapies, Inc. |
Enhanced artificial viral envelopes for cellular delivery of therapeutic substances
|
|
US6013516A
(en)
|
1995-10-06 |
2000-01-11 |
The Salk Institute For Biological Studies |
Vector and method of use for nucleic acid delivery to non-dividing cells
|
|
PL332875A1
(en)
|
1996-10-17 |
1999-10-25 |
Oxford Biomedica Ltd |
Retroviral vectors
|
|
JPH10313865A
(ja)
|
1997-05-15 |
1998-12-02 |
Deinabetsuku Kenkyusho:Kk |
ヒト補体制御因子が呈示されたベクター
|
|
WO1999013905A1
(en)
|
1997-09-18 |
1999-03-25 |
The Trustees Of The University Of Pennsylvania |
Receptor-binding pocket mutants of influenza a virus hemagglutinin for use in targeted gene delivery
|
|
GB9720465D0
(en)
|
1997-09-25 |
1997-11-26 |
Oxford Biomedica Ltd |
Dual-virus vectors
|
|
US5994136A
(en)
|
1997-12-12 |
1999-11-30 |
Cell Genesys, Inc. |
Method and means for producing high titer, safe, recombinant lentivirus vectors
|
|
ES2373406T3
(es)
|
1997-12-22 |
2012-02-03 |
Oxford Biomedica (Uk) Limited |
Vectores basados en el virus de la anemia infecciosa equina (vaie).
|
|
GB9803351D0
(en)
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
|
FR2777909B1
(fr)
|
1998-04-24 |
2002-08-02 |
Pasteur Institut |
Utilisation de sequences d'adn de structure triplex pour le tranfert de sequences de nucleotides dans des cellules, vecteurs recombinants contenant ces sequences triplex
|
|
NZ509978A
(en)
|
1998-09-23 |
2002-12-20 |
Austrian Nordic Biotherapeutic |
Removed particles protected against complement mediated destruction
|
|
US6896881B1
(en)
|
1999-09-24 |
2005-05-24 |
Mayo Foundation For Medical Education And Research |
Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family
|
|
DE60132436T2
(de)
|
2000-03-30 |
2008-04-17 |
Oxford Biomedica (Uk) Ltd. |
Retinolsäure-rezeptor beta-2 und gentherapievektoren für die behandlung von neurologischen erkrankungen
|
|
WO2001074861A2
(en)
|
2000-03-31 |
2001-10-11 |
Mayo Foundation For Medical Education And Research |
Compositions and methods for tissue specific gene regulation therapy
|
|
GB0009760D0
(en)
|
2000-04-19 |
2000-06-07 |
Oxford Biomedica Ltd |
Method
|
|
WO2002002765A2
(en)
|
2000-07-05 |
2002-01-10 |
Transgene S.A. |
Chimeric promoters for controlling expression in smooth muscle cells
|
|
US6276394B1
(en)
|
2000-07-11 |
2001-08-21 |
General Valve, Inc. |
Compact stem set with load-balanced rollers for non-lubricated double block and bleed plug valves
|
|
CA2325088A1
(en)
|
2000-12-01 |
2002-06-01 |
Fusogenix Inc. |
Novel membrane fusion proteins derived from poikilothermic reovirus
|
|
ATE452972T1
(de)
|
2001-05-01 |
2010-01-15 |
Ca Nat Research Council |
Induzierbares expressionssystem in eukaryotischen zellen
|
|
CA2464887A1
(en)
|
2001-10-30 |
2003-05-08 |
Biogen, Inc. |
Methods and compositions for treating parkinson's disease
|
|
US20040028687A1
(en)
|
2002-01-15 |
2004-02-12 |
Waelti Ernst Rudolf |
Methods and compositions for the targeted delivery of therapeutic substances to specific cells and tissues
|
|
AU2003258060B2
(en)
|
2002-03-27 |
2007-07-12 |
Baylor College Of Medicine |
Potent oncolytic herpes simplex virus for cancer therapy
|
|
ES2627445T3
(es)
|
2002-05-01 |
2017-07-28 |
Miltenyi Biotec Technology, Inc. |
Partículas de vector de lentivirus resistentes a la inactivación por el complemento
|
|
DE60335672D1
(de)
|
2002-05-14 |
2011-02-17 |
Merck Sharp & Dohme |
Verfahren zur reinigung von adenovirus
|
|
CA2503317A1
(en)
|
2002-10-24 |
2004-05-06 |
Dnavec Research Inc. |
Method of transferring gene into t cells
|
|
PL377161A1
(pl)
|
2002-11-21 |
2006-01-23 |
Pevion Biotech Ltd. |
Wysoce efektywne pęcherzyki fuzogenne, sposób ich wytwarzania oraz kompozycje farmaceutyczne zawierające te pęcherzyki
|
|
US7842673B2
(en)
|
2003-12-17 |
2010-11-30 |
The Trustees Of Columbia University In The City Of New York |
Delivery of DNA or RNA via gap junctions from host cells to target cells and a cell-based delivery system for antisense or siRNA
|
|
US20060045910A1
(en)
|
2004-09-02 |
2006-03-02 |
Ehringer William D |
Preserved fusogenic vesicles
|
|
WO2006027202A1
(en)
|
2004-09-06 |
2006-03-16 |
Unite De Recherche En Biotherapie Et Oncologie (Rubio) |
Generation of multiparent cell hybrids
|
|
JP2008518630A
(ja)
|
2004-11-08 |
2008-06-05 |
イェール ユニバーシティ |
リボスイッチ、リボスイッチによる、構造を基礎とする化合物設計、ならびにリボスイッチの使用方法およびリボスイッチを伴う組成物
|
|
GB0426641D0
(en)
|
2004-12-03 |
2005-01-05 |
Bioactive Protein Delivery The |
Protein delivery system
|
|
US8034331B2
(en)
|
2005-01-20 |
2011-10-11 |
Agency For Science, Technology And Research |
Method of delivery of nucleic acids to peripheral neurons
|
|
PT1881845E
(pt)
|
2005-04-25 |
2010-05-31 |
Merial Ltd |
Vacinas de vírus nipah
|
|
PL2002003T3
(pl)
|
2005-05-27 |
2016-06-30 |
Ospedale San Raffaele Srl |
Wektor genetyczny zawierający mi-RNA
|
|
WO2007005244A1
(en)
|
2005-07-05 |
2007-01-11 |
The Regents Of The University Of California |
Henipavirus receptor and uses thereof
|
|
WO2007099387A1
(en)
|
2006-03-03 |
2007-09-07 |
Mymetics Corporation |
Virosome-like vesicles comprising gp41-derived antigens
|
|
EP2062246A4
(en)
|
2006-08-18 |
2010-09-29 |
Univ North Carolina |
VACCINES AGAINST CHIMARICAL VIRUSES
|
|
EP1975239A1
(en)
|
2006-09-27 |
2008-10-01 |
Bundesrepublik Deutschland, letztvertreten durch den Präsidenten des Paul-Ehrlich-Instituts Prof. Dr. Johannes Löwer |
Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high-throughput screening
|
|
WO2008071959A1
(en)
|
2006-12-12 |
2008-06-19 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors comprising micrornas
|
|
CN102014934B
(zh)
|
2008-02-22 |
2014-08-20 |
新加坡科技研究局 |
间充质干细胞颗粒
|
|
EP4154903A1
(en)
*
|
2008-04-22 |
2023-03-29 |
Vib Vzw |
Liver-specific nucleic acid regulatory elements and methods and use thereof
|
|
US9296790B2
(en)
|
2008-10-03 |
2016-03-29 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods and compositions for protein delivery
|
|
CN102264349A
(zh)
|
2008-11-07 |
2011-11-30 |
儿童医院医疗中心 |
用于跨膜药物递送系统的鞘脂激活蛋白c以及相关蛋白和肽促融合性质
|
|
US9050269B2
(en)
|
2009-03-10 |
2015-06-09 |
The Trustees Of The University Of Pennsylvania |
Protection of virus particles from phagocytosis by expression of CD47
|
|
JP5667180B2
(ja)
|
2009-07-01 |
2015-02-12 |
イオン メディックス インコーポレイテッド |
哺乳類の有核細胞に由来するマイクロベシクル及びその用途
|
|
ES2455544T5
(es)
|
2009-07-24 |
2017-08-16 |
Immune Design Corp |
Vectores de lentivirus pseudotipificados con una glucoproteína de envoltura de virus sindbis
|
|
ES2693167T3
(es)
|
2009-11-13 |
2018-12-07 |
Inserm - Institut National De La Santé Et De La Recherche Médicale |
Administración directa de proteínas con microvesículas modificadas por ingeniería
|
|
US20120093885A1
(en)
|
2010-10-18 |
2012-04-19 |
Northwestern University |
Therapeutic vesicles
|
|
AU2012249474A1
(en)
|
2011-04-28 |
2013-11-07 |
Stc.Unm |
Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
|
|
WO2012156839A2
(en)
|
2011-05-19 |
2012-11-22 |
Ospedale San Raffaele S.R.L. |
New generation of splice-less lentiviral vectors for safer gene therapy applications
|
|
CN103857387B
(zh)
|
2011-06-02 |
2017-03-15 |
加利福尼亚大学董事会 |
膜包封的纳米颗粒及使用方法
|
|
RU2014100160A
(ru)
|
2011-06-10 |
2015-07-20 |
Блуберд Байо, Инк. |
Векторы генной терапии адренолейкодистрофии и адреномиелонейропатии
|
|
JP2013034401A
(ja)
|
2011-08-04 |
2013-02-21 |
Gunma Univ |
アストロサイトで遺伝子を発現させるためのベクター
|
|
GB201121070D0
(en)
|
2011-12-07 |
2012-01-18 |
Isis Innovation |
composition for delivery of biotherapeutics
|
|
EP2615176A1
(en)
|
2012-01-11 |
2013-07-17 |
Paul-Ehrlich-Institut Bundesamt für Sera und Impfstoffe |
Novel pseudotyped lentiviral particles and their use in the in vitro targeted transduction of undifferentiated pluripotent human embryonic stem cells and induced pluripotent stem cells
|
|
WO2013148327A1
(en)
|
2012-03-26 |
2013-10-03 |
The Regents Of The University Of California |
Nipah virus envelope psuedotyped lentiviruses and methods of their use
|
|
EP2839032A4
(en)
|
2012-04-16 |
2015-11-18 |
Univ Texas |
PROOF OF EXCELLULAR JCV MIRNA
|
|
ES2686129T3
(es)
|
2012-11-13 |
2018-10-16 |
Codiak Biosciences, Inc. |
Administración de agentes terapéuticos
|
|
GB201313249D0
(en)
|
2013-07-25 |
2013-09-11 |
Isis Innovation |
Method
|
|
EA037503B1
(ru)
|
2014-01-21 |
2021-04-05 |
Анджариум Байосайенсиз Аг |
Способ получения гибридосомы, гибридосома, полученная при помощи способа, и способ доставки терапевтического или диагностического средства
|
|
US9668147B2
(en)
|
2014-01-22 |
2017-05-30 |
Maxlinear, Inc. |
Autoconfigured backhaul transceiver
|
|
CA2945335A1
(en)
|
2014-04-18 |
2015-10-22 |
Editas Medicine, Inc. |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
GB201412494D0
(en)
|
2014-07-14 |
2014-08-27 |
Ospedale San Raffaele And Fond Telethon |
Vector production
|
|
US10501733B2
(en)
|
2015-02-27 |
2019-12-10 |
University Of Washington |
Polypeptide assemblies and methods for the production thereof
|
|
US20180135012A1
(en)
|
2015-05-13 |
2018-05-17 |
Rubius Therapeutics, Inc. |
Membrane-receiver complex therapeutics
|
|
WO2016196350A1
(en)
|
2015-05-29 |
2016-12-08 |
New York University |
Auf1 encoding compositions for muscle cell uptake, satellite cell populations, and satellite cell mediated muscle generation
|
|
WO2016210170A1
(en)
|
2015-06-23 |
2016-12-29 |
The Children's Hospital Of Philadelphia |
Modified factor ix, and compositions, methods and uses for gene transfer to cells, organs and tissues
|
|
EP3322297B1
(en)
|
2015-07-13 |
2024-12-04 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
US10624849B2
(en)
|
2015-09-28 |
2020-04-21 |
Northwestern University |
Targeted extracellular vesicles comprising membrane proteins with engineered glycosylation sites
|
|
US20170112773A1
(en)
|
2015-10-23 |
2017-04-27 |
Board Of Regents, The University Of Texas System |
Plasma membrane vesicles comprising functional transmembrane proteins
|
|
WO2017151717A1
(en)
|
2016-03-01 |
2017-09-08 |
French Brent A |
Compositions and methods for adeno-associated virus mediated gene expression in myofibroblast-like cells
|
|
IL261713B2
(en)
|
2016-03-19 |
2023-09-01 |
F1 Oncology Inc |
Methods and preparations for the transfer of lymphocytes and their regulated expansion
|
|
WO2017173034A1
(en)
|
2016-03-30 |
2017-10-05 |
The University Of North Carolina At Chapel Hill |
Biological agent-exosome compositions and uses thereof
|
|
WO2017173367A2
(en)
|
2016-03-31 |
2017-10-05 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Extracellular vesicles, methods of making them, and methods of reducing liver uptake of extracellular vesicles
|
|
EP3235908A1
(en)
|
2016-04-21 |
2017-10-25 |
Ecole Normale Superieure De Lyon |
Methods for selectively modulating the activity of distinct subtypes of cells
|
|
JP7072807B2
(ja)
|
2016-06-09 |
2022-05-23 |
アルマ・マテール・ストゥディオルム・ウニベルシータ・ディ・ボローニャ |
細胞内増殖のための改変糖タンパク質ｈを有するヘルペスウイルス
|
|
CN109415698A
(zh)
|
2016-06-16 |
2019-03-01 |
斯隆－凯特林纪念癌症中心 |
工程化Treg细胞
|
|
EP3472318B1
(en)
|
2016-07-08 |
2023-09-06 |
Exuma Biotech Corp. |
Methods and compositions for transducing lymphocytes and regulating the activity thereof
|
|
US20180028600A1
(en)
|
2016-07-15 |
2018-02-01 |
Korea Institute Of Science And Technology |
Novel recombinant exosome and use thereof
|
|
KR20190053179A
(ko)
|
2016-07-26 |
2019-05-17 |
센티 바이오사이언시스, 인코포레이티드 |
유전자 지우개들
|
|
JP7483373B2
(ja)
|
2016-07-29 |
2024-05-15 |
ジュノー セラピューティクス インコーポレイテッド |
複製可能ウイルスの存在または非存在を評価するための方法
|
|
EP3540056A4
(en)
|
2016-11-10 |
2020-06-03 |
Kaneka Corporation |
METHOD FOR PRODUCING TRANSGENIC CELLS
|
|
AU2018206485B2
(en)
|
2017-01-09 |
2024-12-05 |
Oisin Biotechnologies |
Fusogenic lipid nanoparticles and methods for manufacturing and use for therapeutic protein production and for treatment
|
|
AU2018266111B2
(en)
*
|
2017-05-08 |
2024-11-07 |
Flagship Pioneering Innovations V, Inc. |
Compositions for facilitating membrane fusion and uses thereof
|
|
US20210187018A1
(en)
|
2017-12-07 |
2021-06-24 |
Flagship Pioneering Innovations V, Inc. |
Cytobiologics and therapeutic uses thereof
|
|
AU2019215063B2
(en)
|
2018-02-01 |
2025-10-16 |
Bioverativ Therapeutics, Inc. |
Use of lentiviral vectors expressing Factor VIII
|
|
CA3091478A1
(en)
|
2018-02-17 |
2019-08-22 |
Flagship Pioneering Innovations V, Inc. |
Compositions and methods for membrane protein delivery
|
|
AU2019269593A1
(en)
|
2018-05-15 |
2020-11-26 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
EP3820509A1
(en)
|
2018-07-09 |
2021-05-19 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions and uses thereof
|
|
EP3880832A1
(en)
|
2018-11-14 |
2021-09-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
SG11202105079QA
(en)
|
2018-11-14 |
2021-06-29 |
Flagship Pioneering Innovations V Inc |
Fusosome compositions for cns delivery
|
|
US12496274B2
(en)
|
2018-11-14 |
2025-12-16 |
Flagship Pioneering Innovations V, Inc. |
Compositions and methods for compartment-specific cargo delivery
|
|
WO2020102503A2
(en)
|
2018-11-14 |
2020-05-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for t cell delivery
|